Children experiencing attention deficit hyperactivity disorder face symptoms that can persist, emerge, or fade away completely as they grow older. A recent study published in Nature Mental Health revealed that these different symptom paths are physically reflected in how the brain develops during adolescence, specifically in the growth and thinning of certain brain regions. The research highlights the potential for using brain scans to predict future symptom changes and emphasizes the need for long-term monitoring even after medical treatment begins.
Attention deficit hyperactivity disorder, commonly known as ADHD, affects around five percent of children and adolescents worldwide. This developmental condition often results in varying clinical outcomes as children grow into teenagers and young adults. Some individuals continue to experience symptoms into adulthood, while others go through a remitting phase where their symptoms largely fade. Still, others follow an emergent path where behavioral issues actually worsen over time.
Predicting which adolescents will follow which path remains extremely difficult. A central reason for this difficulty is a lack of long-term brain imaging data showing exactly how adolescent brains mature. The physical development of the brain during these transitional years involves intense structural changes, including a major biological process called synaptic pruning.
During synaptic pruning, the brain naturally eliminates unused neural connections to increase mental efficiency. This normal trimming process causes the outer layer of the brain, known as the cerebral cortex, to thin over time. Variations in how quickly or slowly this thinning occurs can fundamentally impact how a person processes information, pays attention, and regulates their emotions later in life.
Qiang Luo, a researcher at Fudan University in China, led an international team of scientists to explore how typical brain maturation maps onto attention deficit hyperactivity disorder. The team wanted to know if specific physical brain changes corresponded to different developmental symptom paths. They also evaluated whether standard medications prescribed for the condition altered those physical brain development paths.
The research team examined longitudinal data from the Adolescent Brain Cognitive Development study. This massive ongoing project tracks thousands of youth in the United States over many years, measuring environmental, physical, and mental health factors. The team focused on a diverse overarching group of 7,436 adolescents who received initial brain scans at roughly ten years of age.
The researchers categorized the adolescents into four distinct groups based on behavioral assessments provided over a subsequent two-year period. A massive control group experienced no elevated psychiatric symptoms. A much smaller persistent group showed high symptom levels at the beginning and the end of the two years. A remitting group started with high symptoms that eventually faded below the diagnostic threshold. Finally, an emergent group started with low symptoms that eventually worsened to clinical levels.
Assessments of the brain scans over time revealed distinct physical signatures for each group. The persistent group exhibited a faster rate of cortical thinning in certain frontal areas of the brain compared to the healthy control group. These specific frontal regions are typically associated with executive functions like complex decision making and cognitive control. An accelerated thinning is linked to deficits in these daily cognitive abilities.
In the emergent group, the brain also showed altered developmental rates. Individuals whose symptoms worsened over time demonstrated a slower rate of cortical thinning in the right posterior cingulate cortex. This region is a key component of the brain’s default mode network, which helps regulate mind-wandering and internal thoughts. By retaining connections that would typically be pruned away, the developing brain might struggle to shift focus outward when required in a classroom or social setting.
The remitting group, on the other hand, displayed a completely different biological signature. Adolescents whose symptoms faded experienced a faster physical volume expansion of the left hippocampus. The hippocampus is a deeper, primitive brain structure heavily involved in memory formation and emotion regulation. As this region grew faster, the adolescents showed corresponding behavioral improvements in school engagement, prosocial behaviors, and sleep quality.
To understand why these structural brain changes were happening, the researchers compared their localized brain maps to spatial gene expression databases. They analyzed which genes are naturally highly active in these specific changing brain regions. They found a strong overlap with genes responsible for organizing cellular synapses and managing chemical messengers like dopamine and serotonin.
This genetic overlap provides a deep biological foundation for the outward behavioral changes observed. It suggests that the physical volume shifts seen on the brain scans are tied to the fundamental cellular processes governing how local neurons communicate with one another. Tracking these physical parameters essentially allows scientists to view genetic activity playing out on a large scale.
The researchers then investigated the role of ongoing medication use in these developmental outcomes. They matched adolescents with similar symptom severity at the start of the study who either received or did not receive medical treatments. The analysis showed that taking prescribed medication initially was not statistically significant in predicting an individual’s eventual entry into the remitting trajectory.
This lack of association between medication and sustained remission is an unexpected finding. Medical treatments for attention deficit hyperactivity disorder are widely recognized as highly effective at managing immediate behavioral symptoms. However, they might not fundamentally alter the underlying physical development of the brain over the long term. The researchers noted that individuals experiencing symptom remission still exhibited some persisting sleep problems and emotional regulation issues.
Following their initial physical analysis, the team tested whether these newly discovered brain signatures could forecast future behaviors. They fed the baseline brain scan data and behavioral scores into a machine learning computer model. The model accurately predicted symptom severity in the participants three years later at age thirteen. The physical brain measurements improved the accuracy of the predictions beyond using simple behavioral checklists alone.
The team subsequently validated their predictive model using completely separate groups of research participants. One validation group consisted of young adults aged twenty-three in a European neuroscience study. The researchers successfully replicated the specific link between hippocampal expansion and fading symptoms across both the young adult group and two other independent clinical samples. Observing this exact same brain expansion pattern in differing age groups bolsters the reliability of the initial finding.
The current study possesses some limitations to keep in mind. Because the research is observational, it cannot prove that the physical changes in the cortex and hippocampus directly cause symptom improvements or deteriorations. The findings only demonstrate a strong correlation between particular physical brain development rates and changing symptom paths over time.
Additionally, the different datasets used varying questionnaires to measure participant behavioral symptoms, which makes exact comparisons across the separate groups slightly complicated. The available information regarding the participants’ complete medication dosing histories was also somewhat limited. The researchers caution against drawing definitive conclusions about long-term drug impacts based purely on parental reports of recent medication usage.
Moving forward, scientists will need to conduct more frequent brain scans over longer periods to capture the true fluid dynamics of brain development. Focusing on lifestyle interventions that naturally influence continuous hippocampus growth, such as consistent aerobic exercise, might aid in creating new non-pharmacological therapies. By identifying the physical brain markers for these symptom paths, researchers have established a biological roadmap for developing targeted interventions aimed at bringing about long-lasting symptom remission.
The study, “Cortical thinning and hippocampal expansion as brain signatures of attention deficit hyperactivity disorder symptom trajectories,” was published in Nature Mental Health and was authored by Wenjie Hou, Daqian Zhu, Barbara J. Sahakian, Samuele Cortese, Christelle Langley, Lizhu Luo, Qingyang Li, Zixin Gu, Luolong Cao, Gareth J. Barker, Arun L. W. Bokde, Rüdiger Brühl, Sylvane Desrivières, Herta Flor, Hugh Garavan, Penny Gowland, Antoine Grigis, Andreas Heinz, Jean-Luc Martinot, Marie-Laure Paillère Martinot, Eric Artiges, Frauke Nees, Dimitri Papadopoulos Orfanos, Luise Poustka, Michael N. Smolka, Sarah Hohmann, Nathalie Holz, Nilakshi Vaidya, Henrik Walter, Robert Whelan, Gunter Schumann, Li Yang, Tobias Banaschewski, Qiang Luo, and the IMAGEN Consortium.
